Skip to main content
TipRanks
Go Ultimate75% OFF

JD Health International, Inc. (6618) Stock Price & Analysis

25 Followers

6618 Stock Chart & Stats

HK$41.22-HK$0.06(-0.15%)
At close: 4:00 PM GMT+8
HK$35HK$37.5HK$40HK$42.5Aug 24Sep 7Sep 21Oct 5Oct 20Nov 2Nov 16
Day’s Range
HKD 40.18 - HKD 41.88
52-Week Range
HKD 31.84 - HKD 71.70
Previous Close
HKD 41.28
Volume
N/A
Average Volume (3M)
9.21M
Market Cap
HKD 131.51B
Enterprise Value
HKD 49.29B
Total Cash (Recent Filing)
HKD 47.41B
Total Debt (Recent Filing)
HKD 874.69M
Price to Earnings (P/E)
18.2
Beta
1.26
Next Earnings
Mar 29, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Healthy Revenue And Product Growth

Strong product growth and diversified service revenue indicate continued platform demand and expanding commercial reach. Sustained adoption can support operating leverage, reinforce JD Health’s ecosystem position, and provide a durable base for growth over the next several quarters.

Sustained Margin Expansion

Nine consecutive quarters of year-over-year margin improvement provide evidence that profitability gains are becoming operationally repeatable. Better procurement, scale benefits, and expense discipline can strengthen earnings quality and support management’s long-term high-single-digit margin objective.

Conservative Balance Sheet And Strong Liquidity

Extremely low leverage and substantial liquidity give JD Health meaningful financial flexibility. The company can continue investing in pharmacies, technology, and partnerships while retaining capacity to withstand operating volatility without relying heavily on external financing.

Bears Say

Free Cash Flow Reset

A zero free-cash-flow outcome after several positive years signals weaker cash conversion and greater investment or working-capital demands. If this persists, internally funded expansion and capital returns could become less flexible even though operating cash generation remains positive.

Supplement Regulation And Counterfeit-brand Headwinds

Regulatory scrutiny and counterfeit-brand issues can disrupt nutrition and supplement demand while requiring greater compliance and execution. Although management views the long-term effect as favorable for compliant players, category volatility may weigh on growth and mix over the coming quarters.

AI Monetization Remains Unproven

Rapid user growth has not yet translated into a validated independent revenue stream, leaving the economic payoff from AI investment uncertain. Continued spending may improve efficiency and conversion, but monetization could take longer and contribute less to near-term earnings than expected.

JD Health International, Inc. News

6618 FAQ

What was JD Health International, Inc.’s price range in the past 12 months?
JD Health International, Inc. lowest stock price was HK$31.84 and its highest was HK$71.70 in the past 12 months.
What is JD Health International, Inc.’s market cap?
JD Health International, Inc.’s market cap is HK$131.51B.
When is JD Health International, Inc.’s upcoming earnings report date?
JD Health International, Inc.’s next earnings report is estimated for Mar 29, 2027 (not yet confirmed), which is in 131 days.
How were JD Health International, Inc.’s earnings last quarter?
JD Health International, Inc. released its earnings results on Aug 13, 2026. The company reported HK$1.259 earnings per share for the quarter, missing the consensus estimate of HK$1.377 by -HK$0.118.
Is JD Health International, Inc. overvalued?
According to Wall Street analysts JD Health International, Inc.’s price is currently Undervalued.
Does JD Health International, Inc. pay dividends?
JD Health International, Inc. does not currently pay dividends.
What is JD Health International, Inc.’s EPS estimate?
JD Health International, Inc.’s EPS estimate is 1.17.
How many shares outstanding does JD Health International, Inc. have?
JD Health International, Inc. has 3,190,481,000 shares outstanding.
What happened to JD Health International, Inc.’s price movement after its last earnings report?
JD Health International, Inc. reported an EPS of HK$1.259 in its last earnings report, missing expectations of HK$1.377. Following the earnings report the stock price went up 1.698%.
Which hedge fund is a major shareholder of JD Health International, Inc.?
Currently, no hedge funds are holding shares in HK:6618
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology